Stocks with a similar structural profile to Vertex Pharmaceuticals Incorporated (VRTX) — identified by trajectory similarity across revenue dynamics, margin structure, and capital efficiency patterns. Not based on sector labels alone.
Companies similar to Vertex Pharmaceuticals Incorporated cluster around comparable structural characteristics, with the strongest visible overlap typically appearing in quality. Examples in this group include Amgen Inc., Regeneron Pharmaceuticals, Inc., Genmab A/S.
| # | Company | Growth | Quality | Valuation | |
|---|---|---|---|---|---|
| #1 | 75 |
50 |
73 |
VRTX vs AMGN | |
| #2 | 22 |
63 |
80 |
VRTX vs REGN | |
| #3 | 17 |
46 |
66 |
VRTX vs GMAB.CO | |
| #4 | 67 |
100 |
69 |
VRTX vs VRSK | |
| #5 | 44 |
78 |
41 |
VRTX vs EW | |
| #6 | 40 |
61 |
10 |
VRTX vs ARM | |
| #7 | 22 |
67 |
81 |
VRTX vs IGG.L | |
| #8 | 83 |
91 |
86 |
VRTX vs INCY | |
| #9 | 62 |
40 |
19 |
VRTX vs ABBV | |
| #10 | 44 |
59 |
62 |
VRTX vs QIA.DE |
Interactive similarity view, compare tool and portfolio context for Vertex Pharmaceuticals Incorporated.
Each company above has its own structural peer group. Explore the network:
Similarity is rule-based and descriptive only. Based on trajectory analysis of revenue dynamics, margin structure and capital efficiency patterns over time. Not investment advice. Not based on sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.